Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tony Wood Insider Profile
4 Followers
Tony Wood, Chief Scientific Officer at GlaxoSmithKline, holds ― shares in GlaxoSmithKline (Ticker: GB:GSK).
Tony Wood GlaxoSmithKline (GSK)Chief Scientific Officer
GlaxoSmithKline (GSK)
Chief Scientific Officer
Ranked #53,107 out of 100,370 Corporate Insiders
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-2.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Tony Wood does not currently own shares as a corporate insider.
A breakdown of Tony Wood's holdings
Insider Roles
Chief Scientific Officer
Roles that Tony Wood holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tony Wood
Tony Wood's Trading History
List of latest transactions for each holding click on a transaction to see Tony Wood's performance on stock
You May Also Like
Tony Wood insider profile FAQ
What is the percentage of profitable transactions made by Tony Wood?
The percentage of profitable transactions made by Tony Wood is 50%.
What is the average return per transaction made by Tony Wood?
The average return per transaction made by Tony Wood is -2.10%.
What stocks does Tony Wood hold?
Tony Wood holds: GB:GSK stocks.
What was Tony Wood’s latest transaction?
Tony Wood latest transaction was an Uninformative Buy of 11.84K.
What was Tony Wood's most profitable transaction?
Tony Wood’s most profitable transaction was an Informative Sell of GB:GSK stock on February 13, 2024. The return on the trade was 14.10%.
What is Tony Wood's role in GlaxoSmithKline?
Tony Wood's role in GlaxoSmithKline is Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.